Skip to main content

Articles

Page 131 of 376

  1. Authors: AR Santana, FF Amorim, FB Soares, LG de Souza Godoy, L de Jesus Almeida, TA Rodrigues, GM de Andrade Filho, TA Silva, LC de Carvalho Santos, MPB de Araújo, PN Ferreira Jr, APP Amorim, EB de Moura, JA de Araújo Neto and M de Oliveira Maia
    Citation: Critical Care 2013 17(Suppl 3):P59

    This article is part of a Supplement: Volume 17 Supplement 3

  2. Authors: AR Santana, FF Amorim, FB Soares, LG de Souza Godoy, L de Jesus Almeida, TA Rodrigues, GM de Andrade Filho, TA Silva, OG da Silva Neto, PHG Rocha, PN Ferreira Jr, APP Amorim, E Bastos de Moura, JA de Araújo Neto and M de Oliveira Maia
    Citation: Critical Care 2013 17(Suppl 3):P39

    This article is part of a Supplement: Volume 17 Supplement 3

  3. Authors: AR Santana, FF Amorim, FB Soares, LG de Souza Godoy, L de Jesus Almeida, TA Rodrigues, G Menezes de Andrade Filho, TA Silva, JL de Souza, KCM Ogliari, PN Ferreira Jr, APP Amorim, EB de Moura, JA de Araújo Neto and M de Oliveira Maia
    Citation: Critical Care 2013 17(Suppl 3):P30

    This article is part of a Supplement: Volume 17 Supplement 3

  4. Authors: HH Shieh, ER Barreira, EJ Troster, SC Brassica, AC Ventura, PF Góes, I de COF Fernandes, DC de Souza, JC Fernandes, F Pereira das Chagas, R de Jesus, LO Zagne, FR Caino, AE Gilio, G Galvão de França, M Luglio…
    Citation: Critical Care 2013 17(Suppl 3):P17

    This article is part of a Supplement: Volume 17 Supplement 3

  5. H7N9 influenza is a new emerging infection and has high mortality. Both chest radiography and computed tomography (CT) had some limitations in assessing such patients. We performed daily lung ultrasound in a p...

    Authors: Peng Shen, You-ming Zong, Jing Shu, Yun-chao Shi, Wen-jun Zhu, Hui-jiang Qian, Mao-xian Yang and Mao Zhang
    Citation: Critical Care 2013 17:438
  6. New oral anticoagulants, including dabigatran, rivaroxaban, and apixaban, have been recently approved for primary and secondary prophylaxis of thromboembolic conditions. However, there is no clear strategy for...

    Authors: Alejandro Lazo-Langner, Eddy S Lang and James Douketis
    Citation: Critical Care 2013 17:230
  7. Estimation of kidney function in critically ill patients with acute kidney injury (AKI), is important for appropriate dosing of drugs and adjustment of therapeutic strategies, but challenging due to fluctuatio...

    Authors: Gudrun Bragadottir, Bengt Redfors and Sven-Erik Ricksten
    Citation: Critical Care 2013 17:R108
  8. The management reporting and assessment of glycemic control lacks standardization. The use of different methods to measure the blood glucose concentration and to report the performance of insulin treatment yie...

    Authors: Simon Finfer, Jan Wernerman, Jean-Charles Preiser, Tony Cass, Thomas Desaive, Roman Hovorka, Jeffrey I Joseph, Mikhail Kosiborod, James Krinsley, Iain Mackenzie, Dieter Mesotten, Marcus J Schultz, Mitchell G Scott, Robbert Slingerland, Greet Van den Berghe and Tom Van Herpe
    Citation: Critical Care 2013 17:229
  9. The obesity paradox has been used to describe the observed phenomenon described by several studies that indicated improved survival for critically ill patients with mild to moderate obesity when compared with ...

    Authors: Roland N Dickerson
    Citation: Critical Care 2013 17:154
  10. A protective role for glucocorticoid therapy in animal models of sepsis was shown many decades ago. In human sepsis, there is new interest in glucocorticoid therapy at a physiological dose after reports of imp...

    Authors: Julia Guerrero, Héctor A Gatica, Margarita Rodríguez, Roberto Estay and Irmgadt Annelise Goecke
    Citation: Critical Care 2013 17:R107